| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/PAS.0B013E31816380C4 |
| P698 | PubMed publication ID | 18469706 |
| P50 | author | James M Ford | Q91654639 |
| P2093 | author name string | Iris Schrijver | |
| Teri A Longacre | |||
| Amreen Husain | |||
| Kristin C Jensen | |||
| Nicki Chun | |||
| M Rajan Mariappan | |||
| Girish V Putcha | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsatellite | Q265193 |
| DNA mismatch repair | Q2984243 | ||
| P304 | page(s) | 1029-1037 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | The American Journal of Surgical Pathology | Q7713508 |
| P1476 | title | Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. | |
| P478 | volume | 32 |
| Q49413515 | Association of histone deacetylase expression with histology and prognosis of ovarian cancer |
| Q84030213 | Atypical identification of Lynch syndrome by immunohistochemistry and microsatellite instability analysis on jejunal adenocarcinoma |
| Q40505485 | Classification and characterization of microsatellite instability across 18 cancer types |
| Q55399645 | DNA damage repair in ovarian cancer: unlocking the heterogeneity. |
| Q26796491 | Deficient mismatch repair: Read all about it (Review) |
| Q36059087 | Do hereditary syndrome-related gynecologic cancers have any specific features? |
| Q33647555 | HNF-1β in ovarian carcinomas with serous and clear cell change |
| Q28085485 | Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? |
| Q38067433 | Hereditary gynaecological malignancies: advances in screening and treatment |
| Q92560448 | High homogeneity of MMR deficiency in ovarian cancer |
| Q35821477 | Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary |
| Q56889396 | Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches |
| Q38170877 | Mismatch repair deficiency in ovarian cancer -- molecular characteristics and clinical implications |
| Q52678656 | Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer. |
| Q42613711 | Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors? |
| Q48107196 | Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer. |
| Q40073731 | Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas |
| Q33940195 | Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC) |
| Q38142818 | The utility of immunohistochemistry for providing genetic information on tumors |
| Q28536689 | Type-specific cell line models for type-specific ovarian cancer research |
Search more.